<DOC>
	<DOCNO>NCT01604395</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety effectiveness growth hormone ( Eutropin Inj./Eutropin plus Inj . ) treatment GHD ( Growth Hormone Deficiency ) , TS ( Turner Syndrome ) , CRF ( Chronic Renal Failure ) , SGA ( Small Gestational Age ) , ISS ( Idiopathic Short Stature ) .</brief_summary>
	<brief_title>Long-term Safety Effectiveness Growth Hormone With GHD , TS , CRF , SGA ISS Children</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Dwarfism</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>short stature child age 2 year child GHD , TS , CRF , SGA ISS write informed consent person , person 's parent legal guardian</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>GHD</keyword>
	<keyword>TS</keyword>
	<keyword>CRF</keyword>
	<keyword>SGA</keyword>
	<keyword>ISS</keyword>
</DOC>